MedPath

The Sciatica-PLDD trial: a prospective randomised controlled efficiency and efficacy trial on percutaneous laser disc decompression as a treatment modality for sciatica caused by a lumbar disc herniatio

Not Applicable
Completed
Conditions
Sciatica
Musculoskeletal Diseases
Dorsalgia
Registration Number
ISRCTN25884790
Lead Sponsor
eiden University Medical Centre (LUMC) (Netherlands)
Brief Summary

1. 2009 protocol in http://www.ncbi.nlm.nih.gov/pubmed/19439098 2. 2015 results in: https://www.ncbi.nlm.nih.gov/pubmed/25614151 (added 10/07/2019) 3. 2017 results in: https://www.ncbi.nlm.nih.gov/pubmed/28454511 (added 10/07/2019)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
115
Inclusion Criteria

1. Patient aged 18 - 70 years
2. At least 8 weeks of persisting sciatic pain with or without paresis or sensory impairment
3. Patients must qualify for surgical intervention
4. Clear unilateral lumbar disc herniation on computed tomography (CT) or magnetic resonance imaging (MRI) with a anteroposterior diameter less than 33% of the spinal canal
5. Informed consent

Exclusion Criteria

1. Previous discectomy at the same level
2. Cauda equina syndrome
3. Lytic or degenerative spondylolisthesis
4. Spinal/lateral recess stenosis
5. Intervertebral disc space of less than 7 mm
6. Signs of sequestration
7. Pregnancy
8. Serious co-morbidity, either somatic or psychiatric
9. Emigration in the near future
10. No or insufficient knowledge of the Dutch language

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Roland Disability Questionnaire for Sciatica
Secondary Outcome Measures
NameTimeMethod
<br> 1. A cost-effectiveness-analysis will be carried out on the basis of health-related utility factors. This will include costs of sickness absence and long-term disability.<br> 2. Neurological and radiological parameters<br>
© Copyright 2025. All Rights Reserved by MedPath